Financials
- Market Capitalization 126.55 M
- Employee 29
- Founded 2014
- CEO N/A
- Website www.cuebiopharma.com
- Headquarter Delaware, United States
- FIGI BBG00FVMPFN7
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3872 | ENGN enGene Therapeutics Inc. - Common Stock | 1.90 USD | +2.15% | +1.60% | +9.20% | -77.38% | 127.28 M USD | ||
| 3874 | GUTS Fractyl Health, Inc. - Common Stock | 0.80 USD | +5.26% | 0.00% | -6.98% | -46.67% | 126.92 M USD | ||
| 3879 | VTVT vTv Therapeutics Inc. - Class A Common Stock | 31.88 USD | +0.95% | -6.57% | -2.18% | +55.51% | 125.57 M USD | ||
| 3886 | FBIO Fortress Biotech, Inc. - Common Stock | 3.73 USD | +13.03% | +24.75% | +32.27% | +92.27% | 123.91 M USD |
Frequently asked questions about Cue Biopharma, Inc. - Common Stock
What is the Cue Biopharma, Inc. - Common Stock stock price today?
The current price of Cue Biopharma, Inc. - Common Stock (CUE) is 31.28. Over the past 24 hours, the stock has changed by +1.16%. Follow the CUE chart for real-time price dynamics.
What is the stock ticker of Cue Biopharma, Inc. - Common Stock?
Cue Biopharma, Inc. - Common Stock trades under the ticker CUE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Cue Biopharma, Inc. - Common Stock stock going up?
CUE has changed by -3.28% over the last week, +21.10% over the last month, and +4368.57% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Cue Biopharma, Inc. - Common Stock net income for the last quarter?
Cue Biopharma, Inc. - Common Stock reported net income of -5.18 M for the last quarter. The previous quarter showed 1.58 M, which means net income changed by -426.69%.
How many employees does Cue Biopharma, Inc. - Common Stock have?
As of the latest available data, Cue Biopharma, Inc. - Common Stock has 29 employees. Workforce size can provide additional context about the company's scale and operations.
What is Cue Biopharma, Inc. - Common Stock EBITDA?
Cue Biopharma, Inc. - Common Stock EBITDA is -5.28 M, and its EBITDA margin is -92.98%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Cue Biopharma, Inc. - Common Stock stock?
You can buy Cue Biopharma, Inc. - Common Stock (CUE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Cue Biopharma, Inc. - Common Stock stock?
Investing in Cue Biopharma, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CUE chart and related analysis on metatrader.com as part of your research.